Blue Owl Capital Holdings LP Compass Therapeutics, Inc. Transaction History
Blue Owl Capital Holdings LP
- $194 Million
- Q1 2025
A detailed history of Blue Owl Capital Holdings LP transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 2,954,712 shares of CMPX stock, worth $7.89 Million. This represents 2.9% of its overall portfolio holdings.
Number of Shares
2,954,712
Previous 2,954,712
-0.0%
Holding current value
$7.89 Million
Previous $4.28 Million
31.02%
% of portfolio
2.9%
Previous 1.83%
Shares
3 transactions
Others Institutions Holding CMPX
# of Institutions
127Shares Held
101MCall Options Held
2.52MPut Options Held
3.1M-
Orbimed Advisors LLC San Diego, CA22.4MShares$59.7 Million1.32% of portfolio
-
Tang Capital Management LLC San Diego, CA11.1MShares$29.5 Million1.36% of portfolio
-
Blackstone Inc New York, NY10MShares$26.8 Million0.09% of portfolio
-
Bio Impact Capital LLC Cambridge, MA8.44MShares$22.5 Million2.97% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$17.7 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $270M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...